Center for Digestive and Liver Diseases, Inc.  © 2013  |  Privacy policy

like us

Protocol Merit-UC

 

A trial to investigate the safety and efficacy of 25 mg MTX applied subcutaneously once weekly in patients with active UC, who either failed 5-ASA therapy, or are steroid dependent or are intolerant or not responding to azathioprine/6-mercaptopurine therapy or have no response/ lost response to infliximab prior to the study inclusion.

 

Randomized, Double Blind, Prospective Trial Investigating the Efficacy of Methotrexate in Induction and Maintenance of Steroid Free Remission in Ulcerative Colitis

 

 

 

I am interested in more information about this study.

SEND CLEAR